Gemmer Asset Management LLC Organon & Co. Transaction History

Gemmer Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$31.66 - $38.9 $18,236 - $22,406	-576 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$30.45 - $39.36 $121 - $157	-4 Reduced 0.69%	576 $20,000
Q4 2021 Jan 21, 2022	SELL	$28.67 - $37.13 $57 - $74	-2 Reduced 0.34%	580 $18,000
Q3 2021 Oct 19, 2021	BUY	$28.63 - $35.64 $6,155 - $7,662	215 Added 58.58%	582 $19,000
Q2 2021 Jul 23, 2021	BUY	$28.45 - $38.0 $10,441 - $13,946	367 New	367 $11,000

775

190M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.02B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.